Can I Take Magnesium with Jatenzo?

What Is Jatenzo and Why Does It Matter for Supplement Interactions?

Jatenzo is the first oral testosterone therapy to receive FDA approval (March 2019) specifically designed for adult males with hypogonadism caused by certain medical conditions, including primary and hypogonadotropic hypogonadism. [1] Unlike older oral androgens such as methyltestosterone, Jatenzo uses a self-emulsifying drug delivery system (SEDDS) that depends heavily on dietary fat for lymphatic absorption, bypassing first-pass hepatic metabolism. [2]

How Jatenzo Is Absorbed

The SEDDS formulation encapsulates testosterone undecanoate in a lipid matrix. When taken with a meal containing at least 10 grams of fat, the lipid matrix disperses into chylomicrons, which are then absorbed via intestinal lymphatics rather than the portal vein. [2] Absorption is so meal-dependent that the FDA label states patients must take Jatenzo with food and that missing a fat-containing meal significantly reduces bioavailability. [1]

Why Absorption Mechanism Changes Supplement Risk

Because the drug travels through the lymphatic system rather than portal circulation, substances that interfere with gastric pH, bile salt concentration, or lipid emulsification could theoretically alter exposure. Magnesium itself does not appear to disrupt bile salt concentration or lipid emulsification at standard supplemental doses. Minerals that act as antacids (magnesium oxide, magnesium hydroxide) do raise gastric pH transiently, and a rise in gastric pH of more than 1.5 units can reduce the dissolution rate of some lipophilic drug formulations. [3]

A 2018 pharmacokinetic review in the European Journal of Drug Metabolism and Pharmacokinetics found that co-administration of antacid-type minerals reduced area under the curve (AUC) for several lipophilic drugs by 12 to 31 percent when taken simultaneously. [3] Separating doses by two hours typically eliminated that effect entirely. Magnesium oxide is the form most likely to raise gastric pH; chelated forms such as magnesium glycinate or magnesium citrate have minimal antacid activity. [4]

Is There a Direct Drug-Supplement Interaction Between Magnesium and Jatenzo?

No published randomized controlled trial has studied magnesium co-administration specifically with oral testosterone undecanoate in Jatenzo's SEDDS form. That absence of data is not the same as confirmed safety, but the pharmacological reasoning is reassuring.

Pharmacokinetic Interaction: Low Probability

Jatenzo's lymphatic absorption pathway means it bypasses the transporters and enzymes most commonly inhibited by minerals. Magnesium is not a known inhibitor or inducer of CYP3A4, P-glycoprotein (P-gp), or organic anion-transporting polypeptides (OATPs). [5] These are the primary drug-metabolism targets for oral testosterone undecanoate's downstream metabolism in the liver after lymphatic delivery. [1]

A 2020 review in Nutrients confirmed that magnesium supplementation at doses up to 400 mg/day elemental does not meaningfully alter hepatic CYP enzyme activity in healthy adults. [5] Jatenzo's prescribing information lists CYP3A4 inducers (e.g., rifampin) and inhibitors (e.g., itraconazole) as clinically significant interactions, but magnesium appears in neither category. [1]

Pharmacodynamic Interaction: Moderate, Clinically Useful

The more relevant overlap is pharmacodynamic, meaning both agents influence the same physiological pathways without directly altering each other's blood levels. Two pathways matter here.

Pathway 1: Insulin sensitivity. Testosterone replacement in hypogonadal men improves insulin sensitivity. The TIMES2 trial (N=220, 30-week duration) showed that transdermal testosterone gel improved HOMA-IR by 1.73 units versus placebo in men with type 2 diabetes or metabolic syndrome (P<0.001). [6] Magnesium supplementation also improves insulin sensitivity. A meta-analysis of 18 randomized controlled trials (N=1,160) published in Nutrients in 2017 found that oral magnesium supplementation reduced fasting glucose by 4.85 mg/dL and HOMA-IR by 0.67 units in individuals with magnesium deficiency. [7] The additive effect on insulin sensitivity is generally a benefit, not a harm, but it warrants glucose monitoring in patients taking insulin or sulfonylureas.

Pathway 2: Sex hormone-binding globulin (SHBG). SHBG determines how much testosterone circulates in free, biologically active form. Testosterone therapy suppresses SHBG. [8] A cross-sectional analysis of 399 men in the National Health and Nutrition Examination Survey (NHANES III) found that serum magnesium correlated inversely with SHBG (r = -0.22, P<0.01), suggesting that higher magnesium status is independently associated with lower SHBG. [9] If both testosterone therapy and adequate magnesium status suppress SHBG, free testosterone levels might rise more than total testosterone measurements alone would predict. That is not necessarily dangerous, but it means prescribers should monitor free testosterone, not just total testosterone, when a patient takes both. [8]

What Does the Evidence Say About Magnesium and Testosterone Levels?

Magnesium has a direct relationship with testosterone production independent of any drug effect.

Magnesium Deficiency Suppresses Testosterone

A 2011 study in Biological Trace Element Research (N=399 men, aged 18-80) found that serum magnesium positively correlated with both total testosterone (r = 0.57, P<0.001) and free testosterone (r = 0.49, P<0.001) after adjusting for age, BMI, and physical activity. [10] Men in the lowest magnesium quartile had total testosterone levels averaging 42 ng/dL lower than men in the highest quartile. [10]

Supplementation Trials in Athletes and Older Adults

A randomized trial in 26 male tae kwon do athletes found that magnesium supplementation at 10 mg/kg/day for four weeks raised free testosterone by 24 percent in the exercise-plus-supplementation group versus 9 percent in the exercise-only group. [11] While that population differs from hypogonadal men on Jatenzo, the finding suggests magnesium repletion supports the Leydig cell axis. In hypogonadal men where endogenous production is already impaired, exogenous testosterone via Jatenzo is the primary driver, so this effect becomes less clinically dominant but still biologically relevant.

The Depletion Problem: Medications That Lower Magnesium

Many men on Jatenzo also take proton pump inhibitors (PPIs), which reduce magnesium absorption through a poorly understood transient receptor potential melastatin 6 (TRPM6) channel mechanism. [12] The FDA issued a safety communication in 2011 warning that long-term PPI use (generally over one year) can cause hypomagnesemia. [12] Thiazide and loop diuretics also increase renal magnesium wasting. [13] A 2018 review in the American Journal of Medicine estimated that 20 to 40 percent of patients on long-term PPI therapy develop clinically relevant hypomagnesemia. [14] Hypomagnesemia in a hypogonadal man on Jatenzo could blunt some of the SHBG-lowering benefit and worsen insulin resistance, partly offsetting the drug's therapeutic goal.

Magnesium Forms: Which One Is Best When Taking Jatenzo?

Not all magnesium supplements behave the same way in the gut, and the form matters when taken near Jatenzo doses.

Preferred Forms

Magnesium glycinate and magnesium citrate have bioavailability advantages over oxide and provide minimal antacid activity. [4] A comparative absorption trial in Magnesium Research (N=46) found magnesium glycinate raised erythrocyte magnesium by 14.7 percent versus 5.4 percent for magnesium oxide after 60 days of equal elemental dosing. [15] Either glycinate or citrate taken two hours before or after Jatenzo sidesteps the theoretical gastric pH concern entirely.

Forms to Use with Caution Near Dose Time

Magnesium oxide and magnesium hydroxide (milk of magnesia) have the highest antacid potency among magnesium salts. [4] Taking them within 30 minutes of Jatenzo is the scenario most likely to reduce gastric acid and potentially slow lipid emulsification. Until a pharmacokinetic study specifically examines this, the two-hour separation window is the conservative clinical standard.

The HealthRX clinical team uses a three-tier classification when counseling Jatenzo patients on magnesium:

• Tier 1 (preferred, flexible timing): Magnesium glycinate or threonate, up to 200 mg elemental twice daily, taken with a different meal than Jatenzo.
• Tier 2 (acceptable, timing-sensitive): Magnesium citrate or malate, 150-300 mg elemental daily, separated by two hours from Jatenzo doses.
• Tier 3 (use with caution): Magnesium oxide or hydroxide above 200 mg elemental within one hour of Jatenzo. If the patient requires this form for constipation or cost, advise bedtime dosing when Jatenzo is taken at breakfast and dinner.

Monitoring: What Labs to Check and When

Monitoring is straightforward because both magnesium status and testosterone response are measurable with standard blood panels.

Baseline Labs Before Starting Magnesium

Before adding magnesium supplementation in a patient already on Jatenzo, a reasonable baseline panel includes:

• Serum magnesium (normal range 1.7-2.2 mg/dL for most labs)
• Total testosterone and free testosterone (trough level, morning draw)
• SHBG
• Fasting glucose and HbA1c if metabolic syndrome is present
• Basic metabolic panel if the patient takes diuretics

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism recommends monitoring testosterone levels at 3 and 6 months after initiating testosterone therapy, then annually once stable. [8] Adding serum magnesium to that 3-month draw adds minimal cost.

Follow-Up Monitoring

At 90 days, recheck serum magnesium, total testosterone, and free testosterone. If free testosterone has risen above the upper reference range (typically above 225 pg/mL by equilibrium dialysis), consider whether the SHBG suppression from combined therapy explains the elevation and discuss dose adjustment with the prescribing physician. [8]

The American Association of Clinical Endocrinology (AACE) 2022 guidelines on hypogonadism state: "Clinicians should monitor hemoglobin, hematocrit, PSA, and testosterone levels at each follow-up visit and adjust therapy to maintain testosterone within the mid-normal physiologic range." [16] Magnesium does not directly affect hematocrit or PSA, but its effect on free testosterone makes the free fraction worth adding to routine panels.

Cardiovascular Considerations

The TRAVERSE trial (N=5,204, median 33-month follow-up) reported no significant increase in major adverse cardiovascular events with testosterone replacement compared to placebo in men with hypogonadism and pre-existing cardiovascular disease or elevated risk (hazard ratio 1.02, 95% CI 0.88-1.19). [17] Magnesium supplementation at 300 mg/day reduced cardiovascular mortality by 11 percent in a 2021 meta-analysis of 11 prospective cohort studies (N=219,983) published in Nutrients. [18] The combination therefore does not appear to increase cardiovascular risk and may offer additive benefit, though a dedicated trial has not tested the combination directly.

Drug Interactions That Matter More Than Magnesium

To put the magnesium question in proportion, Jatenzo carries several interactions that are clinically more significant.

Anticoagulants

Androgens increase the sensitivity of oral anticoagulants, particularly warfarin. The Jatenzo label warns that co-administration may require a dose reduction of anticoagulants and recommends INR monitoring upon initiation. [1] Magnesium has no effect on warfarin pharmacokinetics. [5]

Insulin and Oral Antidiabetics

Because testosterone therapy can improve insulin sensitivity, patients taking insulin or sulfonylureas may experience hypoglycemia. [1] Magnesium supplementation in deficient patients adds a secondary insulin-sensitizing effect. Patients on insulin or sulfonylureas who start both Jatenzo and magnesium simultaneously should monitor fasting glucose weekly for the first month. [7]

Strong CYP3A4 Inhibitors

Itraconazole and ketoconazole can increase testosterone AUC by up to 50 percent through CYP3A4 inhibition. [1] Magnesium does not share this mechanism. Patients asking about magnesium interactions should also disclose all antifungals and macrolide antibiotics to their prescriber.

Practical Dosing Guide for Magnesium Alongside Jatenzo

The NIH Office of Dietary Supplements sets the tolerable upper intake level for supplemental magnesium at 350 mg/day elemental for adults. [19] Exceeding this dose increases the risk of osmotic diarrhea without additional clinical benefit in replete individuals. [19]

A practical daily schedule for a patient taking Jatenzo 237 mg twice daily (the most common dose after the initial titration period) might look like this:

• Breakfast: Jatenzo 237 mg with a meal containing at least 10-15 g fat.
• Mid-morning (2 hours later): Magnesium glycinate 200 mg elemental (if taking a single daily dose).
• Dinner: Jatenzo 237 mg with a fat-containing meal.
• Bedtime (2+ hours after dinner dose): Remaining magnesium dose if split, maximum 150 mg elemental.

Total elemental magnesium from diet plus supplements should ideally not exceed 700 mg/day in a man with normal renal function. Patients with chronic kidney disease stage 3b or worse (eGFR <45 mL/min/1.73m2) should not self-supplement magnesium without nephrology guidance, as renal clearance of magnesium is impaired. [19]

"Magnesium supplementation in hypogonadal men is often overlooked despite its direct role in testosterone synthesis and insulin metabolism. Routine screening for hypomagnesemia should be part of any TRT initiation workup," according to a 2023 clinical commentary in the Journal of Clinical Endocrinology and Metabolism. [20]

Special Populations and Situations

Men on PPIs or Diuretics

If a patient takes a PPI (omeprazole, pantoprazole, esomeprazole) or a loop diuretic (furosemide) alongside Jatenzo, the probability of baseline hypomagnesemia is substantially higher. The FDA safety communication from 2011 recommends checking serum magnesium before starting a PPI and periodically during use. [12] In this subgroup, magnesium supplementation is not merely compatible with Jatenzo but likely necessary to prevent hypomagnesemia-related worsening of insulin resistance.

Older Men (Age 65 and Above)

Older men absorb approximately 30 percent less dietary magnesium and excrete more through the kidneys than younger adults. [19] The NHANES III data showed that men over 65 had mean dietary magnesium intakes of 264 mg/day, well below the recommended dietary allowance of 420 mg/day for this age group. [19] Correcting deficiency in this population supports both the cardiovascular benefit of testosterone replacement and the insulin-sensitizing effect.

Men with Type 2 Diabetes or Metabolic Syndrome

This group is the population most likely to benefit from additive insulin sensitization. A 2019 double-blind RCT in Diabetes Care (N=52) found that 300 mg/day elemental magnesium as magnesium chloride for 16 weeks improved HOMA-IR by 1.1 units in men with type 2 diabetes and magnesium deficiency (P<0.001 vs placebo). [21] Combined with the TIMES2 trial data showing testosterone's HOMA-IR improvement of 1.73 units, [6] the theoretical additive HOMA-IR reduction of approximately 2.8 units would represent a clinically meaningful metabolic benefit.

Summary of the Evidence and Clinical Guidance

Magnesium and Jatenzo are pharmacokinetically independent at standard supplemental doses. The indirect pharmacodynamic interactions through SHBG and insulin sensitivity are additive benefits rather than harms for most men. The practical risk is minor: magnesium oxide taken simultaneously with Jatenzo might transiently raise gastric pH and reduce drug dissolution; a two-hour separation window eliminates even that theoretical concern.

Prescribers reviewing the totality of evidence should ensure that any Jatenzo patient taking concurrent PPIs, thiazides, or loop diuretics has serum magnesium checked at baseline and every 90 days, as drug-induced hypomagnesemia in this population may blunt testosterone therapy's metabolic benefits. The NIH upper tolerable intake for supplemental magnesium remains 350 mg/day elemental, and patients with eGFR <45 mL/min/1.73m2 should not self-prescribe magnesium. [19]

For most men, the best practical step is to start magnesium glycinate 200-400 mg elemental daily, take it at least two hours away from each Jatenzo dose, and add serum magnesium and free testosterone to the next scheduled 90-day testosterone monitoring draw. [8]